Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01391
|
|||||
Drug Name |
Clomifene
|
|||||
Synonyms |
Androxal; Chlomaphene; Chloramifene; Cisclomifenum; Cisclomiphene; Clomifen; Clomifeno; Clomifenum; Clomifert; Clomiphene; Clostilbegit; Enclomifene; Enclomifeno; Enclomifenum; Enclomiphen; Enclomiphene; Klostilbegit; Transclomifenum; Transclomiphene; Zuclomifene; Zuclomifeno; Zuclomifenum; Zuclomiphene; Clomiphene B;Enclomiphene [USAN]; ISOMER B; Zuclomiphene [USAN]; Cis-Clomifene; Cis-Clomiphene; Clomid (TN); Clomifene (INN); Clomifene (TN); Clomifene [INN:BAN]; Clomifeno [INN-Spanish]; Clomifenum [INN-Latin]; En-Clomiphene; Enclomifeno [INN-Spanish]; Enclomifenum [INN-Latin]; Enclomiphene (USAN); Milophene (TN); RMI 16,289; RMI-16289; RMI-16312; Serophene (TN); Trans-Clomifene; Trans-Clomiphene; Zuclomifeno [INN-Spanish]; Zuclomifenum [INN-Latin]; Zuclomiphene (USAN); Cis-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; Trans-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; Cis-2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; Trans-2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; (E)-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; (Z)-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; (Z)-isomer; 1-(p-(beta-Diethylaminoethoxy)-phenyl)-1,2-diphenylchloroethylene; 2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; 2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; 2-(p-(beta-Chloro-alpha-phenylstyryl)phenoxy)-triethylamine; 2-(p-(beta-chloro-alpha-phenylstyryl)phenoxy)triethylamine; 2-({4-[(Z)-2-chloro-1,2-diphenylethenyl]phenyl}oxy)-N,N-diethylethanamine; 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine; 2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine; 2-[4-[(Z)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine; 2-{4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy}-N,N-diethylethanamine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Female infertility [ICD11: GA31] | Approved | [1] | |||
Therapeutic Class |
Fertility Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C26H28ClNO
|
|||||
Canonical SMILES |
CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3
|
|||||
InChI |
InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+
|
|||||
InChIKey |
GKIRPKYJQBWNGO-OCEACIFDSA-N
|
|||||
CAS Number |
CAS 911-45-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 406 | Topological Polar Surface Area | 12.5 | ||
Heavy Atom Count | 29 | Rotatable Bond Count | 9 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
7.2
|
|||||
PubChem CID | ||||||
PubChem SID |
9134
, 7978971
, 7979159
, 8653308
, 14879465
, 32248894
, 46504463
, 47646665
, 48094648
, 48169503
, 48169504
, 49698470
, 50058156
, 50085975
, 50124218
, 51092022
, 56352921
, 57409058
, 75735317
, 81093254
, 85788573
, 90452382
, 92309293
, 93165675
, 93166374
, 96025593
, 103249489
, 104057024
, 110525086
, 117721819
, 124800080
, 124893612
, 126690411
, 131742069
, 135024045
, 139650876
, 164235770
, 175270141
, 176484319
, 179148468
, 184022027
, 198962245
, 223365954
, 224924849
, 250133940
, 251960682
, 252635354
|
|||||
ChEBI ID |
ChEBI:3752
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Clomifene was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.